Drugs that reduce DNA methylation are used in chemotherapy for types of cancer that are caused by hypermethylation of tumour suppressor genes. Drugs which inhibit HDACs (the enzymes that remove acetyl groups from histones) are also being used to treat some types of cancer. This prevents deacetylation and allows genes to remain switched on. The problem is that it’s hard to make these drugs specifically target cancer cells while leaving other cells alone.